The use of sulfasalazine and pentoxifylline (low-cost antitumour necrosis factor drugs) as adjuvant therapy for the treatment of pemphigus vulgaris: a comparative study. [electronic resource]
Producer: 20091224Description: 313-9 p. digitalISSN:- 1365-2133
- Adult
- Aged
- Biomarkers -- blood
- Case-Control Studies
- Chemotherapy, Adjuvant -- methods
- Cost-Benefit Analysis
- Cyclophosphamide -- therapeutic use
- Double-Blind Method
- Drug Therapy, Combination
- Egypt
- Female
- Humans
- Male
- Middle Aged
- Pemphigus -- blood
- Pentoxifylline -- economics
- Phosphodiesterase Inhibitors -- economics
- Steroids -- therapeutic use
- Sulfasalazine -- economics
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.